Cargando…
Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo
BACKGROUND: The success of gene therapy is mostly dependent on the development of gene carrier. Graphene oxide (GO) possesses excellent aqueous solubility and biocompatibility, which is important for its biochemical and medical applications. Our previous work proved that GO can deliver siRNA into ce...
Autores principales: | Wang, Xiaoli, Sun, Qi, Cui, Chunying, Li, Jing, Wang, Yifan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135080/ https://www.ncbi.nlm.nih.gov/pubmed/30233146 http://dx.doi.org/10.2147/DDDT.S169430 |
Ejemplares similares
-
Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery
por: Li, Jing, et al.
Publicado: (2018) -
Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
por: Sun, Qi, et al.
Publicado: (2018) -
Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
por: Bi, Yanzhao, et al.
Publicado: (2016) -
Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy
por: Chen, Si, et al.
Publicado: (2021) -
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment
por: Eljack, Sahar, et al.
Publicado: (2022)